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Abstract The gene encoding glucose 6-phosphate dehydrogen-
ase (G6PD), which plays a pivotal role in cell defense against
oxidative stress, is ubiquitously expressed at widely different
levels in various tissues; moreover, G6PD expression is regulated
by a number of stimuli. In this study we have analyzed the
molecular anatomy of the G6PD core promoter. Our results
indicate that the G6PD promoter is more complex than
previously assumed; G6PD expression is under the control of
several elements that are all required for correct promoter
functioning and, furthermore, a still unidentified mammalian
specific factor is needed.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
In this paper, we analyze the promoter of the human house-
keeping gene encoding glucose 6-phosphate dehydrogenase
(G6PD). The enzyme G6PD has a fundamental role in the
cell, because it catalyzes the ¢rst regulatory step in the pentose
phosphate pathway [1]. Moreover, it has been demonstrated
that G6PD activity is part of the cell defense against oxidative
stress [2,3]. The gene is X-chromosome-linked and its pro-
moter is embedded in a CpG island which is conserved
from mice to humans [4]. The expression of this ubiquitous
gene is strongly di¡erent in various tissues [5,6] and it is regu-
lated by a number of stimuli [1,2,4,7,8]. Identi¢cation of the
elements, present along the G6PD promoter, involved in the
regulation of the gene expression is an important ¢rst step in
elucidating the mechanisms of physiologic di¡erential regula-
tion of G6PD. In this respect, we decided to analyze the
G6PD promoter in detail, starting from the previously re-
ported observation that promoter sequences extending from
3126 to +16 are su⁄cient to drive substantial amounts of
G6PD transcription [9,10]. The analysis of this core promoter,
in mammalian and Drosophila cell lines, identi¢ed several reg-
ulative sites, which are all strictly required for proper pro-
moter functioning, thus revealing a very complex array of
this promoter. We identi¢ed two GC motifs, a TATA box
and an element that overlaps the transcription start site.
This last element, which is essential for basal promoter activ-
ity, seems to require a mammalian speci¢c factor in order to
drive proper transcription.
2. Materials and methods
2.1. Plasmids and transfections
The plasmid pGD126 (3126) contains the region of the G6PD gene
promoter from 3126 to +16 inserted upstream of the CAT gene in the
vector pEmblCAT3 which was modi¢ed to remove a cryptic AP1 site.
In the linker-scanning mutants (LS1^7) 18 bp of wild-type sequence
(3126) have been replaced with an NdeI-XbaI-SalI (NXS) polylinker.
All mutants were analyzed by DNA sequencing. The Sp1 and Sp3
cDNAs mammalian expression plasmids (pCMV-Sp1 and pCMV-
Sp3, Gal4-Sp1) and the Drosophila expression plasmid pPacSp1
have already been described [11^13] and were kindly given by L.
Lania. The cells were cultured and transiently transfected as already
described [9,14]. CAT activity was quanti¢ed using the Molecular
Dynamics PhosphorImager system. (The ratio of the acetylated
form to the total was normalized by comparison with the luciferase
or the L-galactosidase activity.)
2.2. Electrophoretic mobility shift assays and DNase I protection
Gel shift assays were performed using standard methods. The DNA
fragment, labeled using the Klenow enzyme, was incubated with HeLa
nuclear extracts [15] for 30 min at room temperature. To carry out
supershift assays, antibodies were added to the binding assay mixtures
and incubated for 2 h on ice, before the addition of the radiolabeled
probe. DNase I protection experiments were performed using the
Footprinting kit from Pharmacia Biotech. Full length recombinant
Sp1 and Sp3 proteins (Escherichia coli) were kindly given by L. Lania.
2.3. In vitro transcription
In vitro transcription experiments were performed using the HeLa
Cell Transcription kit from Promega. Transcription products were
analyzed by primer extension using a CAT primer, as described else-
where [16].
3. Results
3.1. Analysis of G6PD linker scanning mutants
In order to identify the regulatory elements that are impor-
tant for proper G6PD core promoter functioning, we have
constructed a set of linker scanning mutants, each with
18 bp of the promoter sequence substituted with an unrelated
sequence (Fig. 1). Each construct was transfected into three
di¡erent human cell lines (HeLa, HepG2, WI38) and tested
for CAT activity. Fig. 1 shows that the levels of expression of
the mutants are comparable in the three cell lines. A strong
reduction of promoter activity was observed with the mutants
LS6, LS5 and LS3 in which putative Sp1 binding sites are
mutated (box B and box C, Fig. 1). Moreover, alteration of
sequences including the TATA box (mutant LS2), and the
region surrounding the transcription start site (mutant LS1)
results in a substantial reduction of CAT expression, suggest-
ing that also these core promoter elements might play a prom-
inent role in G6PD core promoter activity. In vitro transcrip-
tion assay of wild-type and linker-scanning mutants, using
nuclear protein extracts from HeLa cells, reinforced these re-
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sults (Fig. 2). Indeed, we found that in vitro transcription
from the LS1 mutant mainly starts eight nucleotides down-
stream of the wild-type start site. The LS2 construct, in which
the TATA box was mutated, showed transcription starting at
multiple heterogeneous sites. These data suggest that a tran-
scription initiator (Inr) element, located between 312 and +6,
is required for e⁄cient promoter activity and also that both
TATA and Inr are required for the correct functioning of the
promoter.
3.2. Sp1 and Sp3 bind to multiple sites in the human
G6PD promoter
It has been suggested [17] that some proteins, which pre-
sumably belong to the Sp1 family, bind the two more distal
GC boxes (A and B) of the G6PD promoter. However, that
research did not distinguish among members of the Sp1 family
that possess similar binding speci¢city. In this respect, we
performed gel shift assays with a G6PD probe (3126/357)
containing the GC boxes A and B (Fig. 1), and nuclear ex-
tracts from HeLa cells. Three DNA-protein complexes were
detected (Fig. 3, lane 2). The formation of all three complexes
was speci¢cally inhibited by competition with a 100-fold mo-
lar excess of cold oligonucleotide corresponding to the con-
sensus Sp1 binding site (lane 1). Furthermore, pre-incubation
of HeLa nuclear extract with Sp1 antibody resulted in the
partial abrogation of the complexes K and L (lane 3), whilst
FEBS 21017 27-10-98
Fig. 1. Promoter activity of linker scanning G6PD mutants. Top, wild-type sequence of G6PD promoter. The underlined regions indicate nu-
cleotides mutated in the LS1^7 constructs; the locations of the three GC boxes determined by sequence computer analysis (A, B, C) and the
transcription start site are indicated. Below, diagram of linker scanning mutants and CAT activity in human cell lines (percentage of wild
type). Data represent averages þ S.D. of at least three independent experiments.
Fig. 2. In vitro analysis of G6PD transcription start site. In vitro
transcription products from control vector (CAT3), wild-type G6PD
promoter (3126), or mutants LS2 and LS1. The arrow on the left
of the gel indicates the major product obtained with the wild type
G6PD promoter (3126).
Fig. 3. Gel retardation assay of DNA sequence containing the GC
boxes A and B.
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pre-incubation with anti-Sp3 antibody merely resulted in the
suppression of complex Q (lane 4). The three complexes were
completely eliminated by pre-incubating the nuclear extract
with both anti-Sp1 and anti-Sp3 antibodies (Fig. 3, lane 5).
Furthermore, we performed DNase protection assays (Fig.
4A,B) to precisely de¢ne the regions of DNA-protein interac-
tion. The same pattern of DNase I protection was observed
with the HeLa extract or with puri¢ed Sp1 and Sp3 proteins.
Three protected regions (I, II and III) were detected: region I
(3126 to 3108) corresponds to the sequences mutated in LS7
(GC box A, Fig. 1), region II (391 to 373) corresponds to
LS6^5 (GC box B), and region III (345 to 325) corresponds
to LS3 (GC box C). As expected, when the mutated sequences
were used as probes in the footprinting experiments, box I was
not protected in LS7, nor box II in LS5 and LS6 or box III in
LS3 (Fig. 4B and data not shown). No protection was de-
tected around the transcription start site.
3.3. Sp1- and Sp3-mediated regulation of the G6PD promoter
The results reported in Figs. 3 and 4 demonstrate that both
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Fig. 4. DNAse I protection assays. A: Gel analysis of wild-type DNA with recombinant protein Sp1 and Sp3. Lanes a, b: naked DNA; lanes
c^n: after reacting with increasing amounts (1, 3, 5 Wg) of recombinant protein, DNA is incubated with 1 U (lanes c^e and i^k) or 2 U (lanes
f^h and l^n) of DNase. Lane o: G+A sequence. B: Gel analysis of DNA from wild-type (3126) or the indicated linker scanning mutants with
HeLa nuclear extract. Each group of ¢ve lanes is made of two naked DNA controls (lanes a, b; f, g; k, l) and three samples of HeLa-treated
DNA digested with increasing amounts of DNase I (1, 2, 3 U) (lanes c^e; h^j; m^o). The regions protected are shown schematically by boxes;
protected sequences are reported.
Fig. 5. Sp1 dependence of G6PD promoter mutants in HeLa cells.
Linker scanning mutants (LS1^7), or G6PD wild-type (3126) con-
structs (10 Wg) are co-transfected in HeLa cells in the presence of a
control or a Sp1 (10 Wg) or/and Sp3 expressing plasmid (15 Wg).
Fold induction was calculated as the activity of each reporter in the
presence of the indicated amount of e¡ector (Sp1 or Sp3) divided
by the activity of the reporter without e¡ector. Data represent aver-
ages þ S.D. of at least three independent experiments.
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Sp1 and Sp3 proteins bind the G6PD promoter at regions
whose integrity is crucial for proper promoter activity. Since
Sp1 and Sp3 have been shown to activate or repress GC box-
containing promoters in a promoter-speci¢c manner
[11,12,18^22], we wanted to determine the transacting ability
of these factors on the G6PD promoter. The analysis of the
constructs described in Fig. 1 indicates that all the constructs
are activated by Sp1 and repressed by Sp3 (Fig. 5), albeit to
di¡erent degrees, suggesting that the boxes A, B and C can
complement each other and that no exclusive region for the
binding of the Sp1 family proteins exists in the G6PD pro-
moter. As regards the relative transcription e⁄ciency of the
various mutants, we noted surprisingly that LS1 is signi¢-
cantly stimulated by Sp1 (fold induction = 11.8), much more
than the wild-type construct (fold induction = 5.7).
3.4. Sp1-mediated regulation of the G6PD promoter in
Drosophila SL2 cells
In order to de¢ne the regulation of the G6PD promoter by
the Sp1 family members in a more controlled manner, we
expressed our constructs in Drosophila cells, which are devoid
of any Sp1 and Sp1-like DNA binding activity [23,24]. Sur-
prisingly, we did not ¢nd any detectable transcriptional activ-
ity of G6PD core promoter either in the presence or in the
absence of the Sp1 co-transfected expression vector. Under
the same conditions, the transcription of a bona ¢de Sp1-
dependent promoter (human c-myc) was stimulated V40
times by Sp1 (XDN, Fig. 6). The analysis of our promoter
mutants in Drosophila cells showed that only the LS1 reporter
was activated by Sp1 (Fig. 6). This construct was also very
e⁄ciently activated by Sp1 in HeLa cells (Fig. 5). Further-
more, in order to exclude the possibility that the heterologous
18 bp sequences present in LS1 may contain a fortuitous
positive transcription element, we constructed a G6PD pro-
moter mutant that contains di¡erent sequences around the
transcriptional start site. The LS8 construct is similar to
LS1, 18 bp of wild-type being substituted by a di¡erent se-
quence. This promoter construct, when co-transfected into
HeLa and Drosophila SL2 cells along with the Sp1 expression
plasmid, shows the same extent of Sp1-mediated activation as
was obtained with the mutant LS1 (data not shown). These
data suggest that the sequence around the start site plays a
critical role in the control of G6PD e⁄cient transcription.
Furthermore, as Sp1 stimulates the transcription of this pro-
moter only in the absence of the natural region around the
start site, we suggest that an essential factor missing in Dro-
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Fig. 7. Activation by Sp1 targeted to G6PD promoter. Left, dia-
gram of G6PDTATA-I and G6PDTATA constructs. Right, the two
constructs (12 Wg) are co-transfected in HeLa cells with the Gal4-
Sp1 expressing plasmid (12 Wg). Fold induction was calculated as in-
dicated in the legend of Fig. 5. Data represent averages þ S.D. of at
least three independent experiments.
Fig. 8. Proposed model of transcriptional regulation of the G6PD
promoter. The binding proteins are shown below, the binding sites
are shown on the line, and the interactive e¡ects of the binding pro-
teins are indicated above. The Sp1 and Sp3 proteins can bind to
sites A, B, C. Top, wild-type promoter: the Inr site has a basal
functional activity and together with the TATA box is essential for
promoter activity. Sp1 factors can act on the wild-type G6PD pro-
moter only in the presence of a mammalian-speci¢c factor(s) (X).
Below, LS1 mutant: in the absence of the Inr element the promoter
is strongly dependent on Sp1, and the Sp1 factors interact directly
with the TATA box.
Fig. 6. Sp1 dependence of G6PD promoter mutants in Drosophila
cells. Linker scanning mutants, LS1^7 (2 Wg), or G6PD wild-type,
3126 (2 Wg) or myc, XDN (2 Wg) constructs are co-transfected in
Drosophila SL2 cells in the presence of a control or a Sp1 express-
ing plasmid (1.5 Wg). Data represent averages þ S.D. of at least three
independent experiments.
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sophila cells is required to obtain full promoter activity in the
wild-type con¢guration.
3.5. Transcriptional activation by Sp1 targeted to
G6PD promoter
A bias in the interpretation of the data from co-transfection
experiments in HeLa cells could be due to the constitutive
expression of both endogenous Sp1 and Sp3 proteins
[11,12]; therefore, we extended our study to HeLa cells using
gene fusion experiments on reporter constructs, in which Sp1
boxes were substituted by the GAL4 binding site (Fig. 7). The
expression vector Gal4-Sp1 [25] was transfected in HeLa cells
and its activity assayed on the reporter constructs. The ex-
pression vector Gal4-Sp1 contains the Sp1 transcriptional ac-
tivation domain fused to the yeast Gal4-DNA binding do-
main. Two di¡erent reporter plasmids were used; the ¢rst
(G6PDTATA-I) contains ¢ve Gal4 binding sites in front of
the G6PD core promoter sequence ranging from 334 to +14;
the second (G6PDTATA) is isogenic to the ¢rst, except for
the fact that the sequence from 312 to +6 is substituted by
the corresponding sequence in the mutant LS1. The results
(Fig. 7) clearly show that the G6PDTATA construct is
more responsive to Gal4-Sp1 than the wild-type construct,
con¢rming the data already obtained both in mammalian
(Fig. 5) and Drosophila cells (Fig. 6), which show that the
G6PD core promoter is more responsive to Sp1 when the
sequence around the start site is mutated.
4. Discussion
In this paper, we identify several DNA elements in the core
promoter of the G6PD gene which are essential for its expres-
sion. Transfection experiments in mammalian cells (Fig. 1)
indicate a prominent role for the sequences corresponding to
the B box (mutants LS6, LS5), the C box (mutant LS3), the
TATA box (mutant LS2) and an element surrounding the
transcription start site (mutant LS1). This last element acts
as an initiator, which de¢nes the site and rate of transcription
together with a non-canonical TATA box (Fig. 2). Moreover,
using electrophoretic mobility shift assays and DNA foot-
printing analysis, we demonstrated that Sp1 and Sp3 proteins
are both capable of binding to promoter DNA sequences
spanning the GC motifs, and we have precisely de¢ned the
region of DNA-protein interactions. We demonstrated that, in
mammalian cells, Sp1 acts as a transcriptional activator while
Sp3 acts as a repressor (Fig. 5). These results suggest that
changes in the cellular ratio of Sp1 and Sp3 could a¡ect
G6PD expression in speci¢c physiological contexts; the bind-
ing of Sp1 and Sp3 to the sites depends on the transcription
factor milieu that may determine the variability in the expres-
sion of the G6PD gene in various tissues. We also observed
that the mutant LS1 is activated much better in mammalian
cells by Sp1 than the wild-type construct (Figs. 5 and 7) and
that the G6PD promoter could not be activated in Drosophila
cells by Sp1 (Fig. 6); activation of the G6PD promoter by Sp1
in Drosophila cells was only possible in the presence of muta-
tions at the origin of transcription (mutant LS1). These results
suggest that Sp1 is not su⁄cient to activate the wild-type
promoter; in order to function the G6PD promoter may re-
quire another essential factor, which is absent in Drosophila
cells but is present in HeLa. This factor is bound, either di-
rectly or indirectly, to the element around the transcription
start site and is fundamental for the interaction with the tran-
scriptional machinery (Fig. 8). An alternative transcription
complex, which is less e⁄cient (Fig. 1) but strongly dependent
on Sp1 (Figs. 5 and 6), may be active in the case of the LS1
mutant; in this case the promoter is essentially under the
control of the TATA box because the element around the
transcription start site is mutated. The amount of endogenous
Sp1, present in mammalian cells, fails to stimulate e⁄cient
transcription and/or to overcome Sp3 repression in the partic-
ular LS1 promoter conformation (Fig. 1), but a high level of
Sp1 can compensate this e¡ect (Fig. 5).
In conclusion, the results reported here clearly indicate that
the G6PD promoter is more complex than previously assumed
and reinforce the model suggesting that transcriptional regu-
latory proteins may prefer to modulate transcription through
core promoters with speci¢c structures. As shown in Fig. 4, in
vitro protection experiments did not reveal any protein bound
to the sequences around the start site. The lack of a footprint
on this region may be due to a speci¢c secondary structure
assumed by this promoter in vivo. In fact, around the tran-
scription start site we can observe an inverted repeat (310/36,
+1/+5), which can loop as shown in Fig. 9. Such a looping
interaction may alter the con¢guration of the promoter and
thereby facilitate its interactions with some speci¢c factor(s).
In order to explore the possibility that one or more factors are
bound to the element overlapping the transcriptional start site
only in the speci¢c secondary structure assumed by the G6PD
promoter in vivo, we are currently setting up in vivo foot-
printing experiments.
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Fig. 9. Prediction of secondary structure. The sequence of the
G6PD promoter containing the TATA box and the initiator element
(326/+16) has been analyzed with the software ‘Fold’ of the Genet-
ics Computer Group (GCG), Madison, WI.
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